Profound Medical Corp.
PROF
Rank in Stocks
#15349
Profound Medical Corp., along with its subsidiaries, operates as a... Profound Medical Corp., along with its subsidiaries, operates as a commercial-stage medical technology firm. The company specializes in creating magnetic resonance (MR) guided ablation therapies designed to address prostate conditions, uterine fibroids, and to provide palliative pain management. Its market reach extends to Canada, Germany, the United States, and Finland. The company's primary offering is the TULSA-PRO system, which is engineered to integrate with magnetic resonance imaging (MRI) scanners within hospitals and clinical treatment facilities. Additionally, Profound Medical offers Sonalleve, a versatile therapeutic platform that treats uterine fibroids, delivers palliative pain relief for bone metastases, and provides non-invasive solutions for uterine fibroid treatment. Profound Medical Corp. maintains its corporate headquarters in Mississauga, Canada.
Share Price
$7.34
Last synced: 2026-11-09
Market Cap
$267.24M
Change (1 day)
1.80%
Change (1 year)
13.45%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Profound Medical Corp. (PROF)
Category
Healthcare
Earnings for Profound Medical Corp. (PROF)
Earnings in Sep 2026 TTM: $-16.84M
According to Profound Medical Corp.'s latest financial reports, its current earnings (TTM) are $-16.84M. In 2025 the company earned $-43.06M, a decrease compared to its 2024 earnings of $-26.48M. The earnings shown on this page are earnings before interest and taxes, or EBIT.
Earnings history for Profound Medical Corp. from 2012 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $-16.84M | -60.89% |
| 2025 | $-43.06M | 62.59% |
| 2024 | $-26.48M | -7.72% |
| 2023 | $-28.70M | 1.11% |
| 2022 | $-28.38M | -7.23% |
| 2021 | $-30.59M | 41.79% |
| 2020 | $-21.58M | 86.13% |
| 2019 | $-11.59M | 4.31% |
| 2018 | $-11.11M | -25.45% |
| 2017 | $-14.91M | 22.71% |
| 2016 | $-12.15M | -1.46% |
| 2015 | $-12.33M | 76.82% |
| 2014 | $-6.97M | -47.07% |
| 2013 | $-13.17M | 45.91% |
| 2012 | $-9.03M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $6.56B | -39,069.87% |
US
|
|
| $6.60B | -39,313.36% |
IE
|
|
| $5.12B | -30,482.48% |
US
|
|
| $3.66B | -21,806.02% |
US
|
|
| $1.43B | -8,606.62% |
US
|
Questions about Profound Medical Corp.'s net income
What is Profound Medical Corp.'s net income?
Profound Medical Corp.'s net income over the last twelve months is $-16.84M, as of Sep 2026.
What was Profound Medical Corp.'s net income in 2025?
In 2025, Profound Medical Corp.'s net income was $-43.06M, compared with $-26.48M in 2024.
How has Profound Medical Corp.'s net income changed since 2020?
From 2020 to 2025, Profound Medical Corp.'s net income was highest in 2020 ($-21.58M) and lowest in 2025 ($-43.06M).
How does Profound Medical Corp.'s net income compare with similar companies?
Profound Medical Corp.'s net income ($-16.84M) is lower than that of all 5 similar companies listed above. The highest among them is Medtronic plc, with $6.60B.